Company: ZVRA
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001437749-25-016523
Chunk: 62

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part I, Item 8
Chunk 62
---
 retain high quality personnel, our ability to pursue our growth strategy will be limited.

     38

      Item 2. 
      Unregistered Sales of Equity Securities AND Use of Proceeds 

Recent Sales of Unregistered Securities

None.

Purchases of Equity Securities By the Issuer and Affiliated Purchasers

None.

      Item 3. 
      Defaults Upon Senior Securities 

Not applicable.

      Item 4. 
      Mine Safety Disclosures 

Not applicable.

    Item 5.  Other Information 

   (a) Disclosure in lieu of reporting on a Current Report on Form 8-K.
    
     None.
    
   (b) Material changes to the procedures by which security holders  may recommend nominees to the board of directors.
    
         None.
    
   (c) Insider Trading Arrangements and Policies.

      On
      March 21, 2025, Neil F. McFarlane, President and Chief Executive Officer, adopted a Rule
     10b5-
     1 trading arrangement that is intended to satisfy the affirmative defense of Rule
     10b5-
     1(c) for the sale of up to
     125,125 shares of the Company’s common stock until
      March 19, 2026.

      On
      March 26, 2025, Adrian W. Quartel, Chief Medical Officer, adopted a Rule
     10b5-
     1 trading arrangement that is intended to satisfy the affirmative defense of Rule
     10b5-
     1(c) for the sale of up to
     79,533 shares of the Company’s common stock until
      March 31, 2026.

      On
      March 27, 2025, R. LaDuane Clifton, Chief Financial Officer and Treasurer, adopted a Rule
     10b5-
     1 trading arrangement that is intended to satisfy the affirmative defense of Rule
     10b5-
     1(c) for the sale of up to
     14,000 shares of the Company’s common stock until
      March 31, 2026.

      On
      March 27, 2025, Joshua Schafer, Chief Commercial Officer, adopted a Rule
     10b5-
     1 trading arrangement that is intended to satisfy the affirmative defense of Rule